Related Experiment Video
Updated: Jan 15, 2026
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
Published on: July 8, 2020
Antiproliferative and Proapoptotic Effects of Chetomin in Human Melanoma Cells
Laura Jonderko1, Anna Choromańska1
1Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.
Abstract:
Melanoma is an aggressive malignancy with poor prognosis in advanced stages, and current therapeutic options provide only limited benefits, highlighting the need for novel treatments. Chetomin, a fungal metabolite isolated from Chaetomium cochliodes, has been reported to exhibit diverse biological activities, yet its effects on melanoma cells remain poorly understood. In this study, we evaluated the antitumor potential of chetomin using the human A375 melanoma cell line. Cell viability was assessed with MTT and CellTiter-Glo® assays, which revealed a significant dose- and time-dependent reduction in proliferation following chetomin exposure. Apoptotic effects were confirmed through Annexin V staining, and immunocytochemical analysis demonstrated a concentration-dependent increase in cleaved PARP1, indicating activation of programmed cell death pathways. Collectively, these findings demonstrate that chetomin effectively inhibits melanoma cell growth and promotes apoptosis. The results suggest that chetomin represents a promising lead compound for melanoma therapy, warranting further investigation into its precise molecular mechanisms.
Insights
Chetomin, a fungal compound, effectively inhibits melanoma cell growth and triggers apoptosis. This study suggests chetomin as a promising candidate for developing novel melanoma treatments.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Melanoma is an aggressive skin cancer with limited treatment options.
- Novel therapeutic strategies are urgently needed for advanced melanoma.
- The anti-cancer effects of chetomin, a fungal metabolite, on melanoma are largely unknown.
Purpose of the Study:
- To investigate the potential of chetomin as an anti-melanoma agent.
- To evaluate the impact of chetomin on melanoma cell proliferation and apoptosis.
Main Methods:
- Human A375 melanoma cells were treated with varying concentrations of chetomin.
- Cell viability was assessed using MTT and CellTiter-Glo assays.
- Apoptosis was analyzed via Annexin V staining and cleaved PARP1 immunocytochemistry.
Main Results:
- Chetomin significantly reduced melanoma cell proliferation in a dose- and time-dependent manner.
- Apoptotic cell death was induced by chetomin, evidenced by Annexin V staining.
- Increased levels of cleaved PARP1 confirmed the activation of apoptosis pathways.
Conclusions:
- Chetomin demonstrates potent anti-proliferative and pro-apoptotic effects on melanoma cells.
- Chetomin shows promise as a lead compound for future melanoma therapies.
- Further research is warranted to elucidate the molecular mechanisms of chetomin's action.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
